Cargando…
A novel pyroptosis-related signature predicts prognosis and response to treatment in breast carcinoma
Background: Pyroptosis is a new form of programmed cell death (PCD), also known as cellular inflammatory necrosis. Its discovery has resulted in a novel approach to the progression and medication resistance of breast cancer (BC). However, there is still a significant gap in the investigation of pyro...
Autores principales: | Yu, Haochen, Fu, Yong, Tang, Zhenrong, Jiang, Linshan, Qu, Chi, Li, Han, Tan, Zhaofu, Shu, Dan, Peng, Yang, Liu, Shengchun |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8833126/ https://www.ncbi.nlm.nih.gov/pubmed/35085103 http://dx.doi.org/10.18632/aging.203855 |
Ejemplares similares
-
A ferroptosis-associated gene signature for the prediction of prognosis and therapeutic response in luminal-type breast carcinoma
por: Peng, Yang, et al.
Publicado: (2021) -
Construction and Validation of an Immune Infiltration-Related Gene Signature for the Prediction of Prognosis and Therapeutic Response in Breast Cancer
por: Peng, Yang, et al.
Publicado: (2021) -
Cuprotosis-Related Genes: Predicting Prognosis and Immunotherapy Sensitivity in Pancreatic Cancer Patients
por: Xu, Yingkun, et al.
Publicado: (2022) -
A mitochondrial function-related LncRNA signature predicts prognosis and immune microenvironment for breast cancer
por: Wang, Yuan, et al.
Publicado: (2023) -
Organoids from patient biopsy samples can predict the response of BC patients to neoadjuvant chemotherapy
por: Shu, Dan, et al.
Publicado: (2022)